FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:408-416 August 9, 2001 Number 6 Next

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Impairment of the protein C anticoagulation pathway is critical to the thrombosis associated with sepsis and to the development of purpura fulminans in meningococcemia. We studied the expression of thrombomodulin and the endothelial protein C receptor in the dermal microvasculature of children with severe meningococcemia and purpuric or petechial lesions.

Methods We assessed the integrity of the endothelium and the expression of thrombomodulin and the endothelial protein C receptor in biopsy specimens of purpuric lesions from 21 children with meningococcal sepsis (median age, 41 months), as compared with control skin-biopsy specimens.

Results The expression of endothelial thrombomodulin and of the endothelial protein C receptor was lower in the patients with meningococcal sepsis than in the controls, both in vessels with thrombosis and in vessels without thrombosis. On electron microscopical examination, the endothelial cells were generally intact in both thrombosed and nonthrombosed vessels. Plasma thrombomodulin levels in the children with meningococcal sepsis (median, 6.4 ng per liter) were higher than those in the controls (median, 3.6 ng per liter; P=0.002). Plasma levels of protein C antigen, protein S antigen, and antithrombin antigen were lower than those in the controls. In two patients treated with unactivated protein C concentrate, activated protein C was undetectable at the time of admission, and plasma levels remained low.

Conclusions In severe meningococcal sepsis, protein C activation is impaired, a finding consistent with down-regulation of the endothelial thrombomodulin–endothelial protein C receptor pathway.

Source Information

From the Departments of Paediatrics (S.N.F., M.L., O.B.H., S.K.) and Pathology (R.D.G.), Imperial College School of Medicine at St. Mary's Hospital, London; the Oklahoma Medical Research Foundation, Oklahoma City (M.S.L., C.T.E.); the Departments of Pathology (Z.L., C.T.E.) and Biochemistry and Molecular Biology (C.T.E.), University of Oklahoma Health Sciences Center, Oklahoma City; the Howard Hughes Medical Institute, Oklahoma City (C.T.E.); and the Departments of Pathology and Microbiology, University of Bristol, Bristol, United Kingdom (R.S.H.).

Address reprint requests to Dr. Levin at the Department of Paediatrics, Imperial College School of Medicine at St. Mary's Hospital, Norfolk Pl., London W2 1PG, United Kingdom, or at m.levin{at}ic.ac.uk.

Full Text of this Article

This article has been cited by other articles:

• Hiroi, T., Deming, C. B., Zhao, H., Hansen, B. S., Arkenbout, E. K., Myers, T. J., McDevitt, M. A., Rade, J. J. (2009). Proteasome Inhibitors Enhance Endothelial Thrombomodulin Expression via Induction of Kruppel-Like Transcription Factors. Arterioscler. Thromb. Vasc. Bio. 29: 1587-1593 [Abstract] [Full Text]  
• Ahmed, I., Nelson, W. B, Biring, T. S, House, C. M, Marini, J., Dahiya, R. (2009). Acute coronary thrombosis in a patient with septic shock without any evidence of disseminated intravascular coagulation. BMJ Case Reports 2009: bcr0520091887-bcr0520091887 [Abstract] [Full Text]  
• Delvaeye, M., Noris, M., De Vriese, A., Esmon, C. T., Esmon, N. L., Ferrell, G., Del-Favero, J., Plaisance, S., Claes, B., Lambrechts, D., Zoja, C., Remuzzi, G., Conway, E. M. (2009). Thrombomodulin Mutations in Atypical Hemolytic-Uremic Syndrome. NEJM 361: 345-357 [Abstract] [Full Text]  
• Looney, M R, Esmon, C T, Matthay, M A (2009). Role of coagulation pathways and treatment with activated protein C in hyperoxic lung injury. Thorax 64: 114-120 [Abstract] [Full Text]  
• de Souza, A. L., Seguro, A. C. (2008). Two centuries of meningococcal infection: from Vieusseux to the cellular and molecular basis of disease. J Med Microbiol 57: 1313-1321 [Abstract] [Full Text]  
• Ito, T., Kawahara, K.-i., Okamoto, K., Yamada, S., Yasuda, M., Imaizumi, H., Nawa, Y., Meng, X., Shrestha, B., Hashiguchi, T., Maruyama, I. (2008). Proteolytic Cleavage of High Mobility Group Box 1 Protein by Thrombin-Thrombomodulin Complexes. Arterioscler. Thromb. Vasc. Bio. 28: 1825-1830 [Abstract] [Full Text]  
• Yeh, C.-H., Hung, L.-Y., Hsu, C., Le, S.-Y., Lee, P.-T., Liao, W.-L., Lin, Y.-T., Chang, W.-C., Tseng, J. T. (2008). RNA-binding Protein HuR Interacts with Thrombomodulin 5'Untranslated Region and Represses Internal Ribosome Entry Site-mediated Translation under IL-1{beta} Treatment. Mol. Biol. Cell 19: 3812-3822 [Abstract] [Full Text]  
• Gandrille, S. (2008). Endothelial cell protein C receptor and the risk of venous thrombosis. haematol 93: 812-816 [Full Text]  
• Schouten, M., Wiersinga, W. J., Levi, M., van der Poll, T. (2008). Inflammation, endothelium, and coagulation in sepsis. J. Leukoc. Biol. 83: 536-545 [Abstract] [Full Text]  
• Borgel, D., Bornstain, C., Reitsma, P. H., Lerolle, N., Gandrille, S., Dali-Ali, F., Esmon, C. T., Fagon, J.-Y., Aiach, M., Diehl, J.-L. (2007). A Comparative Study of the Protein C Pathway in Septic and Nonseptic Patients with Organ Failure. Am. J. Respir. Crit. Care Med. 176: 878-885 [Abstract] [Full Text]  
• de Souza, A. L., Sztajnbok, J., Salgado, M. M., Romano, C. C., Alkmin, M. d. G. A., Duarte, A. J. S., Seguro, A. C. (2007). Severe Myalgia of the Lower Extremities as the First Clinical Feature of Meningococcal Purpura Fulminans. Am J Trop Med Hyg 77: 723-726 [Abstract] [Full Text]  
• Tang, H., Ivanciu, L., Popescu, N., Peer, G., Hack, E., Lupu, C., Taylor, F. B. Jr, Lupu, F. (2007). Sepsis-Induced Coagulation in the Baboon Lung Is Associated with Decreased Tissue Factor Pathway Inhibitor. Am. J. Pathol. 171: 1066-1077 [Abstract] [Full Text]  
• Aird, W. C. (2007). Phenotypic Heterogeneity of the Endothelium: I. Structure, Function, and Mechanisms. Circ. Res. 100: 158-173 [Abstract] [Full Text]  
• Kapur, N. K., Deming, C. B., Kapur, S., Bian, C., Champion, H. C., Donahue, J. K., Kass, D. A., Rade, J. J. (2007). Hemodynamic Modulation of Endocardial Thromboresistance. Circulation 115: 67-75 [Abstract] [Full Text]  
• Feistritzer, C., Schuepbach, R. A., Mosnier, L. O., Bush, L. A., Di Cera, E., Griffin, J. H., Riewald, M. (2006). Protective Signaling by Activated Protein C Is Mechanistically Linked to Protein C Activation on Endothelial Cells. J. Biol. Chem. 281: 20077-20084 [Abstract] [Full Text]  
• Weijer, S., Wieland, C. W., Florquin, S., van der Poll, T. (2005). A thrombomodulin mutation that impairs activated protein C generation results in uncontrolled lung inflammation during murine tuberculosis. Blood 106: 2761-2768 [Abstract] [Full Text]  
• Abraham, E. (2005). Effects of Recombinant Human Activated Protein C in Human Models of Endotoxin Administration. Proc Am Thorac Soc 2: 243-247 [Abstract] [Full Text]  
• Zeerleder, S., Hack, C. E., Wuillemin, W. A. (2005). Disseminated Intravascular Coagulation in Sepsis. Chest 128: 2864-2875 [Abstract] [Full Text]  
• Jarva, H., Ram, S., Vogel, U., Blom, A. M., Meri, S. (2005). Binding of the Complement Inhibitor C4bp to Serogroup B Neisseria meningitidis. J. Immunol. 174: 6299-6307 [Abstract] [Full Text]  
• Sohn, R. H., Deming, C. B., Johns, D. C., Champion, H. C., Bian, C., Gardner, K., Rade, J. J. (2005). Regulation of endothelial thrombomodulin expression by inflammatory cytokines is mediated by activation of nuclear factor-kappa B. Blood 105: 3910-3917 [Abstract] [Full Text]  
• Liaw, P. C. Y., Esmon, C. T., Kahnamoui, K., Schmidt, S., Kahnamoui, S., Ferrell, G., Beaudin, S., Julian, J. A., Weitz, J. I., Crowther, M., Loeb, M., Cook, D. (2004). Patients with severe sepsis vary markedly in their ability to generate activated protein C. Blood 104: 3958-3964 [Abstract] [Full Text]  
• Franscini, N., Bachli, E. B., Blau, N., Leikauf, M.-S., Schaffner, A., Schoedon, G. (2004). Gene Expression Profiling of Inflamed Human Endothelial Cells and Influence of Activated Protein C. Circulation 110: 2903-2909 [Abstract] [Full Text]  
• Ganopolsky, J. G., Castellino, F. J. (2004). A Protein C Deficiency Exacerbates Inflammatory and Hypotensive Responses in Mice During Polymicrobial Sepsis in a Cecal Ligation and Puncture Model. Am. J. Pathol. 165: 1433-1446 [Abstract] [Full Text]  
• Weitz, J. I., Hirsh, J., Samama, M. M. (2004). New Anticoagulant Drugs: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 265S-286S [Abstract] [Full Text]  
• Rijneveld, A. W., Weijer, S., Florquin, S., Esmon, C. T., Meijers, J. C. M., Speelman, P., Reitsma, P. H., Ten Cate, H., van der Poll, T. (2004). Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide. Blood 103: 1702-1709 [Abstract] [Full Text]  
• Sajan, I., Da-Silva, S. S., Dellinger, R. P. (2004). Drotrecogin Alfa (Activated) in an Infant with Gram-Negative Septic Shock. J Intensive Care Med 19: 51-55 [Abstract]  
• Warren, H. S. Jr., Gonzalez, R. G., Tian, D. (2003). Case 38-2003 - A 12-Year-Old Girl with Fever and Coma. NEJM 349: 2341-2349 [Full Text]  
• Dettenmeier, P., Swindell, B., Stroud, M., Arkins, N., Howard, A. (2003). Role of Activated Protein C in the Pathophysiology of Severe Sepsis. Am J Crit Care 12: 518-524 [Abstract] [Full Text]  
• Kerlin, B. A., Yan, S. B., Isermann, B. H., Brandt, J. T., Sood, R., Basson, B. R., Joyce, D. E., Weiler, H., Dhainaut, J.-F. (2003). Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia. Blood 102: 3085-3092 [Abstract] [Full Text]  
• Toh, C. H., Dennis, M. (2003). Disseminated intravascular coagulation: old disease, new hope. BMJ 327: 974-977 [Full Text]  
• Keller, T. T, Mairuhu, A. T.A, de Kruif, M. D, Klein, S. K, Gerdes, V. E.A, ten Cate, H., Brandjes, D. P.M, Levi, M., van Gorp, E. C.M (2003). Infections and endothelial cells. Cardiovasc Res 60: 40-48 [Abstract] [Full Text]  
• Peters, K., Unger, R. E., Brunner, J., Kirkpatrick, C.J. (2003). Molecular basis of endothelial dysfunction in sepsis. Cardiovasc Res 60: 49-57 [Abstract] [Full Text]  
• Riewald, M., Petrovan, R. J., Donner, A., Ruf, W. (2003). Activated protein C signals through the thrombin receptor PAR1 in endothelial cells. Innate Immunity 9: 317-321 [Abstract]  
• Derhaschnig, U., Reiter, R., Knobl, P., Baumgartner, M., Keen, P., Jilma, B. (2003). Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia. Blood 102: 2093-2098 [Abstract] [Full Text]  
• Esmon, C. T. (2003). The Protein C Pathway. Chest 124 : 26S-32S [Abstract] [Full Text]  
• Ware, L. B., Fang, X., Matthay, M. A. (2003). Protein C and thrombomodulin in human acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 285: L514-L521 [Abstract] [Full Text]  
• Almog, Y. (2003). Statins, Inflammation, and Sepsis: Hypothesis. Chest 124: 740-743 [Abstract] [Full Text]  
• Bryant, A. E. (2003). Biology and Pathogenesis of Thrombosis and Procoagulant Activity in Invasive Infections Caused by Group A Streptococci and Clostridium perfringens. Clin. Microbiol. Rev. 16: 451-462 [Abstract] [Full Text]  
• Pathan, N, Faust, S N, Levin, M (2003). Pathophysiology of meningococcal meningitis and septicaemia. Arch. Dis. Child. 88: 601-607 [Abstract] [Full Text]  
• Welch, S B, Nadel, S (2003). Treatment of meningococcal infection. Arch. Dis. Child. 88: 608-614 [Abstract] [Full Text]  
• Aird, W. C. (2003). The Hematologic System as a Marker of Organ Dysfunction in Sepsis. Mayo Clin Proc. 78: 869-881 [Abstract]  
• Levi, M., Dorffler-Melly, J., Reitsma, P., Buller, H., Florquin, S., van der Poll, T., Carmeliet, P. (2003). Aggravation of endotoxin-induced disseminated intravascular coagulation and cytokine activation in heterozygous protein-C-deficient mice. Blood 101: 4823-4827 [Abstract] [Full Text]  
• Kleinpell, R. (2003). Advances in Treating Patients With Severe Sepsis: Role of Drotrecogin Alfa (Activated). Crit Care Nurse 23: 16-29 [Full Text]  
• Esmon, C. T. (2003). Coagulation and inflammation. Innate Immunity 9: 192-198 [Abstract]  
• Peters, M. J., Heyderman, R. S., Faust, S., Dixon, G. L. J., Inwald, D. P., Klein, N. J. (2003). Severe meningococcal disease is characterized by early neutrophil but not platelet activation and increased formation and consumption of platelet-neutrophil complexes. J. Leukoc. Biol. 73: 722-730 [Abstract] [Full Text]  
• Aird, W. C. (2003). The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101: 3765-3777 [Abstract] [Full Text]  
• Morris, P. E. (2003). Meeting Unmet Needs in Patients With Sepsis: the Role of Drotrecogin Alfa (Activated). Am J Crit Care 12: 94-97 [Full Text]  
• Sperry, J. L., Deming, C. B., Bian, C., Walinsky, P. L., Kass, D. A., Kolodgie, F. D., Virmani, R., Kim, A. Y., Rade, J. J. (2003). Wall Tension Is a Potent Negative Regulator of In Vivo Thrombomodulin Expression. Circ. Res. 92: 41-47 [Abstract] [Full Text]  
• Baines, P. B., Hart, C. A. (2003). Severe meningococcal disease in childhood. Br J Anaesth 90: 72-83 [Abstract] [Full Text]  
• Pastores, S M (2003). Drotrecogin alfa (activated): a novel therapeutic strategy for severe sepsis. Postgrad. Med. J. 79: 5-10 [Abstract] [Full Text]  
• Esmon, C. T. (2002). New Mechanisms for Vascular Control of Inflammation Mediated by Natural Anticoagulant Proteins. JEM 196: 561-564 [Full Text]  
• Harrison, O. B., Robertson, B. D., Faust, S. N., Jepson, M. A., Goldin, R. D., Levin, M., Heyderman, R. S. (2002). Analysis of Pathogen-Host Cell Interactions in Purpura Fulminans: Expression of Capsule, Type IV Pili, and PorA by Neisseria meningitidis In Vivo. Infect. Immun. 70: 5193-5201 [Abstract] [Full Text]  
• Hambleton, J., Leung, L. L., Levi, M. (2002). Coagulation: Consultative Hemostasis. ASH Education Book 2002: 335-352 [Abstract] [Full Text]  
• Piette, W. W., Lentz, S. R., Kao, N., Hazelzet, J. A., de Kleijn, E. D., de Groot, R., Faust, S. N., Heyderman, R. S., Levin, M. (2001). Endothelial Protein C Activation in Meningococcal Sepsis. NEJM 345: 1776-1777 [Full Text]  
• Brandtzaeg, P., Bjerre, A., Ovstebo, R., Brusletto, B., Joo, G. B., Kierulf, P. (2001). Invited review: Neisseria meningitidis lipopolysaccharides in human pathology. Innate Immunity 7: 401-420 [Abstract]